C
Claros Diagnostics
Home - OPKO Health, Inc.
About Claros Diagnostics
Claros Diagnostics, operating under the brand name ClarosDx, specializes in providing innovative diagnostic solutions aimed at enhancing patient care. The company leverages advanced technology to offer personalized medicine, ensuring accurate and timely diagnostics. ClarosDx serves healthcare providers, including hospitals, clinics, and medical laboratories, by offering point-of-care testing systems that deliver rapid results. Operating in the healthcare and biotechnology market, ClarosDx employs a business model centered around the sale of diagnostic devices and consumables, as well as offering maintenance and support services. Revenue is generated through the direct sale of these products and services to healthcare institutions. The company’s focus on precision diagnostics and patient-centric solutions positions it as a key player in the evolving landscape of medical technology.
Source: Dealroom company dataAt a glance
- Founded
- 2004
- Headquarters
- Miami, United States
- Sector
- Biotech & Life Sciences
Knowledge graph
More headlines
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A4 investors entered at this stage
- OPOxford Bioscience Partners
- BIBioventures Investors
Commons Capital- APAccelerated Technologies Partners
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Claros Diagnostics on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Claros Diagnostics on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.